全体要約
調剤薬局の伝統的な役割は、商業的に入手できない特定の患者のニーズに応じた薬を調製することです。2023年の調剤薬局市場は11570百万米ドルと推定され、2030年には13970百万米ドルに達する見込みで、2024年から2030年の間に年平均成長率（CAGR）は2.7%です。北米が最大の市場で、55%以上のシェアを占めています。
調剤薬局の主要な製品セグメントはPIAで、30%以上のシェアを持ち、最大のアプリケーションは45歳から64歳の消費者です。市場の主要プレーヤーにはFagron、Wedgewood Pharmacy、CAPS、Fresenius Kabi、Advanced Pharmaなどが含まれ、上位5社で約5%のシェアを保持しています。
関連する質問
11570百万米ドル（2023年）
2.7%（2024年-2030年）
Fagron, Wedgewood Pharmacy, CAPS, Fresenius Kabi, Advanced Pharma, PharMEDium Services, B. Braun Group, New Compounding Pharma, Medisca, AIN GROUP, Nihon Chouzai, Sogo Medical, Dougherty’s Pharmacy, Apollo Pharmacy, Downing Labs, Qol Holdings, Olympia Pharmacy, PUMCH, Triangle Compounding Pharmacy, Peking University First Hospital, Affiliated Hospital of Guangdong Public Institution of Medicine, Lorraine's Pharmacy, PLAGH, Institutional Pharmacy Solutions, Ruijin Hospital, Belle Sante, Byculla Pharmacy&Stores, Royal Chemists, Village Compounding Pharmacy, Specialist Pharmacy
患者の特定ニーズに応じた薬剤のカスタマイズ, 商業的に入手できない薬剤の調製, 特定の年齢層における需要の増加
概要
若い子供は、大人用の錠剤のみで作られた薬の小さな液体の投与量が必要な場合があります。
人は薬の市販版に含まれる成分の一つにアレルギー反応を示すことがあります。
調剤薬局は、問題のある成分を含まない正しい用量と形態の薬を調製します。
調合薬は、患者に必要な正確な強さと用量の形で個々の成分を混ぜる医師の処方に基づいて作られます。この方法により、調合薬剤師は患者と処方者と協力して、患者の特定のニーズに合った薬をカスタマイズすることができます。
2023年のコンパウンディングファーマシーの世界市場は、推定11570百万米ドルの価値があり、2030年までに13970百万米ドルの再調整された規模になると予測されています。この期間中の年平均成長率は2.7%です。
グローバルコンパウンディングファーマシーの主要プレーヤーには、ファグロン、ウェッジウッドファーマシー、CAPS、フレゼニウス・カビ、アドバンスド・ファーマなどが含まれています。グローバルな上位五社のメーカーは、ほぼ5％のシェアを持っています。
北米は最大の市場で、シェアは55％以上です。次いで、ヨーロッパとアジア太平洋が続き、いずれもシェアは35％以上です。
製品に関しては、PIAが最も大きなセグメントであり、市場シェアは30%以上です。また、用途に関しては、最も大きな用途は45歳から64歳の消費者であり、次いで65歳以上の消費者、19歳から44歳の消費者、18歳以下の消費者が続きます。
報告の範囲
この報告書は、コンパウンディングファーマシーのグローバル市場に関する包括的なプレゼンテーションを提供することを目的としており、定量的および定性的な分析を通じて、読者がビジネス/成長戦略を策定し、市場の競争状況を評価し、現在の市場における自社の位置を分析し、コンパウンディングファーマシーに関する情報に基づいたビジネス意思決定を行うのに役立てることを目指しています。
調剤薬局市場の規模、予測、および推定は、基準年を2023年とし、2019年から2030年までの期間の歴史データと予測データに基づいて、収益（百万ドル）で提供されています。このレポートは、世界の調剤薬局市場を包括的にセグメント化しています。また、製品の種類、用途、プレイヤー別に地域ごとの市場規模も提供されています。
市場をより深く理解するために、報告書には競争環境、主要競合企業、およびそれぞれの市場ランクのプロファイルが含まれています。また、報告書では技術動向や新製品の開発についても論じています。
この報告書は、調剤薬局企業、新規参入者、そして業界チェーン関連企業に対して、企業別、製品タイプ別、アプリケーション別、地域別の全体市場およびサブセグメントの収益に関する情報を提供します。
市場セグメンテーション
企業別
PharMEDiumサービス
B. ブラウン グループ
ファグロン
ウェッジウッドファーマシー
新しいコンパウンディングファーマ
メディスカ
フレゼニウス・カビ
アドバンスドファーマ
AINグループ
日本調剤
総合医学
ドウゲルティ薬局
アポロ薬局
ダウニングラボズ
Qolホールディングス
オリンピアファーマシー
パンク
トライアングル調剤薬局
北京大学第一医院
広東省公立医療機関付属病院
ロレーヌ薬局
プラグ
インスティテューショナルファーマシーソリューションズ
瑞金医院
ベルサンテ
バイキュラ薬局＆ストア
ロイヤルケミストリー
ビレッジ・コンパウンディング・ファーマシー
専門薬局
タイプ別セグメント
PIA
PAA
CUPM
PDA
SAPM
アプリケーション別セグメント
18歳以下の消費者
19歳から44歳の消費者
45歳から64歳の消費者
65歳以上の消費者
地域別
北米
アメリカ合衆国
カナダ
ヨーロッパ
ドイツ
フランス
イギリス
イタリア
ロシア
北欧諸国
その他のヨーロッパ
アジア太平洋
中国
日本
韓国
インド
東南アジア
オーストラリア
アジア太平洋地域の残り
ラテンアメリカ
メキシコ
ブラジル
ラテンアメリカの残りの地域
中東およびアフリカ
トルコ
サウジアラビア
UAE（アラブ首長国連邦）
中東およびアフリカの残りの地域
章の概要
第1章：レポートの範囲、異なる市場セグメント（製品タイプ、アプリケーションなど）のエグゼクティブサマリー、市場セグメントごとの市場規模、将来の発展可能性などを紹介します。
第2章：世界および地域レベルにおける調剤薬局の収益。
第3章：調剤薬局企業の競争環境、収益、市場シェア及び業界ランキング、最新の開発計画、合併・買収情報等の詳細な分析です。
第4章：市場における主要企業の基本状況を詳細に紹介し、製品の説明や仕様、調剤薬局の収益、粗利、最近の開発などを含む主要企業のプロフィールを提供します。
第5章：さまざまな市場セグメントのタイプ別分析を提供し、各市場セグメントの収益および発展の可能性をカバーします。この情報は、読者が異なる市場セグメントでブルーオーシャン市場を見つけるのに役立ちます。
第6章：各市場セグメントのアプリケーション別分析を提供し、収益と各市場セグメントの発展可能性をカバーして、読者が異なる下流市場でブルーオーシャン市場を見つけるのを助けます。
第7章：北アメリカ（米国とカナダ）タイプ別、用途別、国別、各セグメントの収益。
第8章：タイプ別、アプリケーション別、国別のヨーロッパ、各セグメントの収益。
第9章：アジア太平洋地域のタイプ、アプリケーションおよび地域別、各セグメントの収益。
第10章：国別、アプリケーション別、タイプ別のラテンアメリカ、各セグメントの収益。
第11章：中東およびアフリカ、タイプ別、アプリケーション別、国別、それぞれのセグメントの収益。
第12章: 産業チェーン、販売チャネル、主要原材料、ディストリビュータ、顧客の分析です。
第13章：市場のダイナミクス、最新の市場動向、市場の推進要因と制約要因、業界内の製造業者が直面する課題とリスク、および業界に関連する政策の分析を紹介します。
第14章: 研究結果と結論
※以下の目次にて、具体的なレポートの構成をご覧頂けます。ご購入、無料サンプルご請求、その他お問い合わせは、ページ上のボタンよりお進みください。
目次
1 調査のカバー範囲
1.1 調剤薬局 : プロダクトのイントロダクション
1.2 市場、タイプ別
1.2.1 グローバルにおける調剤薬局市場規模成長率、タイプ別（2019年 vs 2023年 vs 2030年）
1.2.2 PIA
1.2.3 パー
1.2.4 カップム
1.2.5 Pda
1.2.6 サプム
1.3 市場、用途別
1.3.1 グローバルにおける調剤薬局市場規模成長率、用途別（2019年 vs 2023年 vs 2030年）
1.3.2 18歳以下の消費者
1.3.3 19歳から44歳の消費者
1.3.4 45歳から64歳の消費者
1.3.5 65歳以上の消費者
1.4 前提条件と限界
1.5 調査の目的
1.6 対象年
2 エグゼクティブサマリー
2.1 グローバルにおける調剤薬局市場規模の見積もりと予測
2.2 調剤薬局市場規模、地域別：2023年と2030年の比較
2.2.1 グローバルにおける調剤薬局市場の収益規模、地域別 2019年～2024年
2.2.2 グローバルの調剤薬局収益、市場予測（地域別）（2025年～2030年）
2.2.3 グローバルにおける調剤薬局市場の収益シェア、地域別（2019年～2030年）
3 グローバルにおける調剤薬局、企業別
3.1 グローバルにおける調剤薬局市場の収益規模、企業別（2019年～2024年）
3.2 グローバルにおける調剤薬局市場の収益シェア、企業別（2019年〜2024年）
3.3 競合情勢
3.3.1 Key Compounding Pharmacy Companies around the World: Ranking by Revenue
3.3.2 Global Compounding Pharmacy Market Concentration Ratio \(CR5 and HHI\) & \(2019-2024\)
3.3.3 Global Compounding Pharmacy Market Share by Company Type \(Tier 1, Tier 2 and Tier 3\)
3.4 グローバルにおける調剤薬局の会社所在地と製品タイプ
3.4.1 調剤薬局の会社所在地
3.4.2 グローバルにおける調剤薬局の製品・サービス
3.4.3 国際企業の調剤薬局市場への参入日
3.5 グローバルにおける調剤薬局のM&A、事業拡張計画
4 企業プロファイル
4.1 PharMEDium Services
4.1.1 PharMEDium Services：企業情報
4.1.2 PharMEDium Services：会社概要、事業概要
4.1.3 PharMEDium Services：調剤薬局の製品
4.1.4 PharMEDium Services：調剤薬局の収益および売上総利益率（2019年〜2024年）
4.1.5 PharMEDium Services：製品別の調剤薬局の収益（2023年）
4.1.6 PharMEDium Services：用途別の調剤薬局の収益（2023年）
4.1.7 PharMEDium Services：地理別の調剤薬局の収益（2023年）
4.1.8 PharMEDium Services：近況
4.2 B\. Braun Group
4.2.1 B\. Braun Group：企業情報
4.2.2 B\. Braun Group：会社概要、事業概要
4.2.3 B\. Braun Group：調剤薬局の製品
4.2.4 B\. Braun Group：調剤薬局の収益および売上総利益率（2019年〜2024年）
4.2.5 B\. Braun Group：製品別の調剤薬局の収益（2023年）
4.2.6 B\. Braun Group：用途別の調剤薬局の収益（2023年）
4.2.7 B\. Braun Group：地理別の調剤薬局の収益（2023年）
4.2.8 B\. Braun Group：近況
4.3 Fagron
4.3.1 Fagron：企業情報
4.3.2 Fagron：会社概要、事業概要
4.3.3 Fagron：調剤薬局の製品
4.3.4 Fagron：調剤薬局の収益および売上総利益率（2019年〜2024年）
4.3.5 Fagron：製品別の調剤薬局の収益（2023年）
4.3.6 Fagron：用途別の調剤薬局の収益（2023年）
4.3.7 Fagron：地理別の調剤薬局の収益（2023年）
4.3.8 Fagron：近況
4.4 Wedgewood Pharmacy
4.4.1 Wedgewood Pharmacy：企業情報
4.4.2 Wedgewood Pharmacy：会社概要、事業概要
4.4.3 Wedgewood Pharmacy：調剤薬局の製品
4.4.4 Wedgewood Pharmacy：調剤薬局の収益および売上総利益率（2019年〜2024年）
4.4.5 Wedgewood Pharmacy：製品別の調剤薬局の収益（2023年）
4.4.6 Wedgewood Pharmacy：用途別の調剤薬局の収益（2023年）
4.4.7 Wedgewood Pharmacy：地理別の調剤薬局の収益（2023年）
4.4.8 Wedgewood Pharmacy：近況
4.5 New Compounding Pharma
4.5.1 New Compounding Pharma：企業情報
4.5.2 New Compounding Pharma：会社概要、事業概要
4.5.3 New Compounding Pharma：調剤薬局の製品
4.5.4 New Compounding Pharma：調剤薬局の収益および売上総利益率（2019年〜2024年）
4.5.5 New Compounding Pharma：製品別の調剤薬局の収益（2023年）
4.5.6 New Compounding Pharma：用途別の調剤薬局の収益（2023年）
4.5.7 New Compounding Pharma：地理別の調剤薬局の収益（2023年）
4.5.8 New Compounding Pharma：近況
4.6 Medisca
4.6.1 Medisca：企業情報
4.6.2 Medisca：会社概要、事業概要
4.6.3 Medisca：調剤薬局の製品
4.6.4 Medisca：調剤薬局の収益および売上総利益率（2019年〜2024年）
4.6.5 Medisca：製品別の調剤薬局の収益（2023年）
4.6.6 Medisca：用途別の調剤薬局の収益（2023年）
4.6.7 Medisca：地理別の調剤薬局の収益（2023年）
4.6.8 Medisca直近の動向
4.7 Fresenius Kabi
4.7.1 Fresenius Kabi：企業情報
4.7.2 Fresenius Kabi：会社概要、事業概要
4.7.3 Fresenius Kabi：調剤薬局の製品
4.7.4 Fresenius Kabi：調剤薬局の収益および売上総利益率（2019年〜2024年）
4.7.5 Fresenius Kabi：製品別の調剤薬局の収益（2023年）
4.7.6 Fresenius Kabi：用途別の調剤薬局の収益（2023年）
4.7.7 Fresenius Kabi：地理別の調剤薬局の収益（2023年）
4.7.8 Fresenius Kabi直近の動向
4.8 Advanced Pharma
4.8.1 Advanced Pharma：企業情報
4.8.2 Advanced Pharma：会社概要、事業概要
4.8.3 Advanced Pharma：調剤薬局の製品
4.8.4 Advanced Pharma：調剤薬局の収益および売上総利益率（2019年〜2024年）
4.8.5 Advanced Pharma：製品別の調剤薬局の収益（2023年）
4.8.6 Advanced Pharma：用途別の調剤薬局の収益（2023年）
4.8.7 Advanced Pharma：地理別の調剤薬局の収益（2023年）
4.8.8 Advanced Pharma直近の動向
4.9 AIN GROUP
4.9.1 AIN GROUP：企業情報
4.9.2 AIN GROUP：会社概要、事業概要
4.9.3 AIN GROUP：調剤薬局の製品
4.9.4 AIN GROUP：調剤薬局の収益および売上総利益率（2019年〜2024年）
4.9.5 AIN GROUP：製品別の調剤薬局の収益（2023年）
4.9.6 AIN GROUP：用途別の調剤薬局の収益（2023年）
4.9.7 AIN GROUP：地理別の調剤薬局の収益（2023年）
4.9.8 AIN GROUP直近の動向
4.10 Nihon Chouzai
4.10.1 Nihon Chouzai：企業情報
4.10.2 Nihon Chouzai：会社概要、事業概要
4.10.3 Nihon Chouzai：調剤薬局の製品
4.10.4 Nihon Chouzai：調剤薬局の収益および売上総利益率（2019年〜2024年）
4.10.5 Nihon Chouzai：製品別の調剤薬局の収益（2023年）
4.10.6 Nihon Chouzai：用途別の調剤薬局の収益（2023年）
4.10.7 Nihon Chouzai：地理別の調剤薬局の収益（2023年）
4.10.8 Nihon Chouzai直近の動向
4.11 Sogo Medical
4.11.1 Sogo Medical：企業情報
4.11.2 Sogo Medical：会社概要、事業概要
4.11.3 Sogo Medical：調剤薬局の製品
4.11.4 Sogo Medical：調剤薬局の収益および売上総利益率（2019年〜2024年）
4.11.5 Sogo Medical：製品別の調剤薬局の収益（2023年）
4.11.6 Sogo Medical：用途別の調剤薬局の収益（2023年）
4.11.7 Sogo Medical：地理別の調剤薬局の収益（2023年）
4.11.8 Sogo Medical直近の動向
4.12 Dougherty’s Pharmacy
4.12.1 Dougherty’s Pharmacy：企業情報
4.12.2 Dougherty’s Pharmacy：会社概要、事業概要
4.12.3 Dougherty’s Pharmacy：調剤薬局の製品
4.12.4 Dougherty’s Pharmacy：調剤薬局の収益および売上総利益率（2019年〜2024年）
4.12.5 Dougherty’s Pharmacy：製品別の調剤薬局の収益（2023年）
4.12.6 Dougherty’s Pharmacy：用途別の調剤薬局の収益（2023年）
4.12.7 Dougherty’s Pharmacy：地理別の調剤薬局の収益（2023年）
4.12.8 Dougherty’s Pharmacy直近の動向
4.13 Apollo Pharmacy
4.13.1 Apollo Pharmacy：企業情報
4.13.2 Apollo Pharmacy：会社概要、事業概要
4.13.3 Apollo Pharmacy：調剤薬局の製品
4.13.4 Apollo Pharmacy：調剤薬局の収益および売上総利益率（2019年〜2024年）
4.13.5 Apollo Pharmacy：製品別の調剤薬局の収益（2023年）
4.13.6 Apollo Pharmacy：用途別の調剤薬局の収益（2023年）
4.13.7 Apollo Pharmacy：地理別の調剤薬局の収益（2023年）
4.13.8 Apollo Pharmacy直近の動向
4.14 Downing Labs
4.14.1 Downing Labs：企業情報
4.14.2 Downing Labs：会社概要、事業概要
4.14.3 Downing Labs：調剤薬局の製品
4.14.4 Downing Labs：調剤薬局の収益および売上総利益率（2019年〜2024年）
4.14.5 Downing Labs：製品別の調剤薬局の収益（2023年）
4.14.6 Downing Labs：用途別の調剤薬局の収益（2023年）
4.14.7 Downing Labs：地理別の調剤薬局の収益（2023年）
4.14.8 Downing Labs直近の動向
4.15 Qol Holdings
4.15.1 Qol Holdings：企業情報
4.15.2 Qol Holdings：会社概要、事業概要
4.15.3 Qol Holdings：調剤薬局の製品
4.15.4 Qol Holdings：調剤薬局の収益および売上総利益率（2019年〜2024年）
4.15.5 Qol Holdings：製品別の調剤薬局の収益（2023年）
4.15.6 Qol Holdings：用途別の調剤薬局の収益（2023年）
4.15.7 Qol Holdings：地理別の調剤薬局の収益（2023年）
4.15.8 Qol Holdings直近の動向
4.16 Olympia Pharmacy
4.16.1 Olympia Pharmacy：企業情報
4.16.2 Olympia Pharmacy：会社概要、事業概要
4.16.3 Olympia Pharmacy：調剤薬局の製品
4.16.4 Olympia Pharmacy：調剤薬局の収益および売上総利益率（2019年〜2024年）
4.16.5 Olympia Pharmacy：製品別の調剤薬局の収益（2023年）
4.16.6 Olympia Pharmacy：用途別の調剤薬局の収益（2023年）
4.16.7 Olympia Pharmacy：地理別の調剤薬局の収益（2023年）
4.16.8 Olympia Pharmacy直近の動向
4.17 PUMCH
4.17.1 PUMCH：企業情報
4.17.2 PUMCH：会社概要、事業概要
4.17.3 PUMCH：調剤薬局の製品
4.17.4 PUMCH：調剤薬局の収益および売上総利益率（2019年〜2024年）
4.17.5 PUMCH：製品別の調剤薬局の収益（2023年）
4.17.6 PUMCH：用途別の調剤薬局の収益（2023年）
4.17.7 PUMCH：地理別の調剤薬局の収益（2023年）
4.17.8 PUMCH直近の動向
4.18 Triangle Compounding Pharmacy
4.18.1 Triangle Compounding Pharmacy：企業情報
4.18.2 Triangle Compounding Pharmacy：会社概要、事業概要
4.18.3 Triangle Compounding Pharmacy：調剤薬局の製品
4.18.4 Triangle Compounding Pharmacy：調剤薬局の収益および売上総利益率（2019年〜2024年）
4.18.5 Triangle Compounding Pharmacy：製品別の調剤薬局の収益（2023年）
4.18.6 Triangle Compounding Pharmacy：用途別の調剤薬局の収益（2023年）
4.18.7 Triangle Compounding Pharmacy：地理別の調剤薬局の収益（2023年）
4.18.8 Triangle Compounding Pharmacy直近の動向
4.19 Peking University First Hospital
4.19.1 Peking University First Hospital：企業情報
4.19.2 Peking University First Hospital：会社概要、事業概要
4.19.3 Peking University First Hospital：調剤薬局の製品
4.19.4 Peking University First Hospital：調剤薬局の収益および売上総利益率（2019年〜2024年）
4.19.5 Peking University First Hospital：製品別の調剤薬局の収益（2023年）
4.19.6 Peking University First Hospital：用途別の調剤薬局の収益（2023年）
4.19.7 Peking University First Hospital：地理別の調剤薬局の収益（2023年）
4.19.8 Peking University First Hospital直近の動向
4.20 Affiliated Hospital of Guangdong Public Institution of Medicine
4.20.1 Affiliated Hospital of Guangdong Public Institution of Medicine：企業情報
4.20.2 Affiliated Hospital of Guangdong Public Institution of Medicine：会社概要、事業概要
4.20.3 Affiliated Hospital of Guangdong Public Institution of Medicine：調剤薬局の製品
4.20.4 Affiliated Hospital of Guangdong Public Institution of Medicine：調剤薬局の収益および売上総利益率（2019年〜2024年）
4.20.5 Affiliated Hospital of Guangdong Public Institution of Medicine：製品別の調剤薬局の収益（2023年）
4.20.6 Affiliated Hospital of Guangdong Public Institution of Medicine：用途別の調剤薬局の収益（2023年）
4.20.7 Affiliated Hospital of Guangdong Public Institution of Medicine：地理別の調剤薬局の収益（2023年）
4.20.8 Affiliated Hospital of Guangdong Public Institution of Medicine直近の動向
4.21 Lorraine's Pharmacy
4.21.1 Lorraine's Pharmacy：企業情報
4.21.2 Lorraine's Pharmacy：会社概要、事業概要
4.21.3 Lorraine's Pharmacy：調剤薬局の製品
4.21.4 Lorraine's Pharmacy：調剤薬局の収益および売上総利益率（2019年〜2024年）
4.21.5 Lorraine's Pharmacy：製品別の調剤薬局の収益（2023年）
4.21.6 Lorraine's Pharmacy：用途別の調剤薬局の収益（2023年）
4.21.7 Lorraine's Pharmacy：地理別の調剤薬局の収益（2023年）
4.21.8 Lorraine's Pharmacy直近の動向
4.22 PLAGH
4.22.1 PLAGH：企業情報
4.22.2 PLAGH：会社概要、事業概要
4.22.3 PLAGH：調剤薬局の製品
4.22.4 PLAGH：調剤薬局の収益および売上総利益率（2019年〜2024年）
4.22.5 PLAGH：製品別の調剤薬局の収益（2023年）
4.22.6 PLAGH：用途別の調剤薬局の収益（2023年）
4.22.7 PLAGH：地理別の調剤薬局の収益（2023年）
4.22.8 PLAGH直近の動向
4.23 Institutional Pharmacy Solutions
4.23.1 Institutional Pharmacy Solutions：企業情報
4.23.2 Institutional Pharmacy Solutions：会社概要、事業概要
4.23.3 Institutional Pharmacy Solutions：調剤薬局の製品
4.23.4 Institutional Pharmacy Solutions：調剤薬局の収益および売上総利益率（2019年〜2024年）
4.23.5 Institutional Pharmacy Solutions：製品別の調剤薬局の収益（2023年）
4.23.6 Institutional Pharmacy Solutions：用途別の調剤薬局の収益（2023年）
4.23.7 Institutional Pharmacy Solutions：地理別の調剤薬局の収益（2023年）
4.23.8 Institutional Pharmacy Solutions直近の動向
4.24 Ruijin Hospital
4.24.1 Ruijin Hospital：企業情報
4.24.2 Ruijin Hospital：会社概要、事業概要
4.24.3 Ruijin Hospital：調剤薬局の製品
4.24.4 Ruijin Hospital：調剤薬局の収益および売上総利益率（2019年〜2024年）
4.24.5 Ruijin Hospital：製品別の調剤薬局の収益（2023年）
4.24.6 Ruijin Hospital：用途別の調剤薬局の収益（2023年）
4.24.7 Ruijin Hospital：地理別の調剤薬局の収益（2023年）
4.24.8 Ruijin Hospital直近の動向
4.25 Belle Sante
4.25.1 Belle Sante：企業情報
4.25.2 Belle Sante：会社概要、事業概要
4.25.3 Belle Sante：調剤薬局の製品
4.25.4 Belle Sante：調剤薬局の収益および売上総利益率（2019年〜2024年）
4.25.5 Belle Sante：製品別の調剤薬局の収益（2023年）
4.25.6 Belle Sante：用途別の調剤薬局の収益（2023年）
4.25.7 Belle Sante：地理別の調剤薬局の収益（2023年）
4.25.8 Belle Sante直近の動向
4.26 Byculla Pharmacy&Stores
4.26.1 Byculla Pharmacy&Stores：企業情報
4.26.2 Byculla Pharmacy&Stores：会社概要、事業概要
4.26.3 Byculla Pharmacy&Stores：調剤薬局の製品
4.26.4 Byculla Pharmacy&Stores：調剤薬局の収益および売上総利益率（2019年〜2024年）
4.26.5 Byculla Pharmacy&Stores：製品別の調剤薬局の収益（2023年）
4.26.6 Byculla Pharmacy&Stores：用途別の調剤薬局の収益（2023年）
4.26.7 Byculla Pharmacy&Stores：地理別の調剤薬局の収益（2023年）
4.26.8 Byculla Pharmacy&Stores直近の動向
4.27 Royal Chemists
4.27.1 Royal Chemists：企業情報
4.27.2 Royal Chemists：会社概要、事業概要
4.27.3 Royal Chemists：調剤薬局の製品
4.27.4 Royal Chemists：調剤薬局の収益および売上総利益率（2019年〜2024年）
4.27.5 Royal Chemists：製品別の調剤薬局の収益（2023年）
4.27.6 Royal Chemists：用途別の調剤薬局の収益（2023年）
4.27.7 Royal Chemists：地理別の調剤薬局の収益（2023年）
4.27.8 Royal Chemists直近の動向
4.28 Village Compounding Pharmacy
4.28.1 Village Compounding Pharmacy：企業情報
4.28.2 Village Compounding Pharmacy：会社概要、事業概要
4.28.3 Village Compounding Pharmacy：調剤薬局の製品
4.28.4 Village Compounding Pharmacy：調剤薬局の収益および売上総利益率（2019年〜2024年）
4.28.5 Village Compounding Pharmacy：製品別の調剤薬局の収益（2023年）
4.28.6 Village Compounding Pharmacy：用途別の調剤薬局の収益（2023年）
4.28.7 Village Compounding Pharmacy：地理別の調剤薬局の収益（2023年）
4.28.8 Village Compounding Pharmacy直近の動向
4.29 Specialist Pharmacy
4.29.1 Specialist Pharmacy：企業情報
4.29.2 Specialist Pharmacy：会社概要、事業概要
4.29.3 Specialist Pharmacy：調剤薬局の製品
4.29.4 Specialist Pharmacy：調剤薬局の収益および売上総利益率（2019年〜2024年）
4.29.5 Specialist Pharmacy：製品別の調剤薬局の収益（2023年）
4.29.6 Specialist Pharmacy：用途別の調剤薬局の収益（2023年）
4.29.7 Specialist Pharmacy：地理別の調剤薬局の収益（2023年）
4.29.8 Specialist Pharmacy直近の動向
5 ブレークダウンデータ、タイプ別
5.1 グローバルにおける調剤薬局市場の収益規模、タイプ別（2019年～2024年）
5.2 グローバルの調剤薬局収益、市場予測（タイプ別）（2025年～2030年）
5.3 調剤薬局の収益と市場シェア、タイプ別（2019年〜2030年）
6 ブレークダウンデータ、用途別
6.1 グローバルにおける調剤薬局市場の収益規模、用途別（2019年～2024年）
6.2 グローバルの調剤薬局収益、市場予測（用途別）（2025年～2030年）
6.3 調剤薬局の収益と市場シェア、用途別（2019年〜2030年）
7 北米
7.1 北米における調剤薬局市場規模の前年比成長率、2019年〜2030年
7.2 北米における調剤薬局市場のファクト・数値、 国別（2019年〜2030年）
7.3 北米における調剤薬局市場の収益規模、タイプ別（2019年～2024年）
7.4 北米における調剤薬局市場の収益規模、用途別（2019年～2024年）
8 アジア太平洋
8.1 アジア太平洋における調剤薬局市場規模の前年比成長率、2019年〜2030年
8.2 アジア太平洋における調剤薬局市場のファクト・数値、 地域別（2019年〜2030年）
8.3 アジア太平洋における調剤薬局市場の収益規模、タイプ別（2019年～2024年）
8.4 アジア太平洋における調剤薬局市場の収益規模、用途別（2019年～2024年）
9 ヨーロッパ
9.1 ヨーロッパにおける調剤薬局市場規模の前年比成長率、2019年〜2030年
9.2 ヨーロッパにおける調剤薬局市場のファクト・数値、 国別（2019年〜2030年）
9.3 ヨーロッパにおける調剤薬局市場の収益規模、タイプ別（2019年～2024年）
9.4 ヨーロッパにおける調剤薬局市場の収益規模、用途別（2019年～2024年）
10 ラテンアメリカ
10.1 ラテンアメリカにおける調剤薬局市場規模の前年比成長率、2019年〜2030年
10.2 ラテンアメリカにおける調剤薬局市場のファクト・数値、 国別（2019年〜2030年）
10.3 ラテンアメリカにおける調剤薬局市場の収益規模、タイプ別（2019年～2024年）
10.4 ラテンアメリカにおける調剤薬局市場の収益規模、用途別（2019年～2024年）
11 中東・アフリカ
11.1 中東・アフリカにおける調剤薬局市場規模の前年比成長率、2019年〜2030年
11.2 中東・アフリカにおける調剤薬局市場のファクト・数値、 国別（2019年〜2030年）
11.3 中東・アフリカにおける調剤薬局市場の収益規模、タイプ別（2019年～2024年）
11.4 中東・アフリカにおける調剤薬局市場の収益規模、用途別（2019年～2024年）
12 サプライチェーンと販売チャネル分析
12.1 調剤薬局サプライチェーン分析
12.2 調剤薬局の主要原材料と上流サプライヤー
12.3 調剤薬局の顧客分析
12.4 調剤薬局の販売チャネルと販売モデルの分析
12.4.1 調剤薬局の流通チャネル分析： 間接販売 VS 直接販売
12.4.2 調剤薬局の流通チャネル分析： オンライン販売 VS オフライン販売
12.4.3 調剤薬局の流通業者
13 市場ダイナミクス
13.1 調剤薬局業界トレンド
13.2 調剤薬局市場のドライバー
13.3 調剤薬局市場の課題
13.4 調剤薬局市場の抑制要因
14 調査の結果・結論
15 付録
15.1 調査手法
15.1.1 調査手法 / 調査アプローチ
15.1.2 データソース
15.2 執筆者の詳細
15.3 免責事項
※英文のレポートについての日本語表記のタイトルや紹介文などは、すべて生成AIや自動翻訳ソフトを使用して提供しております。それらはお客様の便宜のために提供するものであり、当社はその内容について責任を負いかねますので、何卒ご了承ください。適宜英語の原文をご参照ください。
“All Japanese titles, abstracts, and other descriptions of English-language reports were created using generative AI and/or machine translation. These are provided for your convenience only and may contain errors and inaccuracies. Please be sure to refer to the original English-language text. We disclaim all liability in relation to your reliance on such AI-generated and/or machine-translated content.”
Description
A young child may need a small, liquid dose of a drug made only in adult-dosage tablets.
A person may be allergic to one of the ingredients in the commercial version of a drug.
A compounding pharmacy would make the proper dosage and form of the drug without any offending ingredients.
Compounded medications are made based on a practitioner’s prescription in which individual ingredients are mixed together in the exact strength and dosage form required by the patient. This method allows the compounding pharmacist to work with the patient and the prescriber to customize a medication to meet the patient’s specific needs.
The global market for Compounding Pharmacy was estimated to be worth US$ 11570 million in 2023 and is forecast to a readjusted size of US$ 13970 million by 2030 with a CAGR of 2.7% during the forecast period 2024-2030.
Global Compounding Pharmacy key players include Fagron, Wedgewood Pharmacy, CAPS, Fresenius Kabi, Advanced Pharma, etc. Global top five manufacturers hold a share nearly 5%.
North America is the largest market, with a share over 55%, followed by Europe, and Asia-Pacific, both have a share over 35 percent.
In terms of product, PIA is the largest segment, with a share over 30%. And in terms of application, the largest application is Consumers Aged 45 to 64, followed by Consumers Aged 65 and Older, Consumers Aged 19 to 44, Consumers Aged 18 and Younger.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Compounding Pharmacy, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyse their position in the current marketplace, and make informed business decisions regarding Compounding Pharmacy.
The Compounding Pharmacy market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Compounding Pharmacy market comprehensively. Regional market sizes, concerning products by type, by application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Compounding Pharmacy companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, product type, application, and regions.
Market Segmentation
By Company
PharMEDium Services
B. Braun Group
Fagron
Wedgewood Pharmacy
New Compounding Pharma
Medisca
Fresenius Kabi
Advanced Pharma
AIN GROUP
Nihon Chouzai
Sogo Medical
Dougherty’s Pharmacy
Apollo Pharmacy
Downing Labs
Qol Holdings
Olympia Pharmacy
PUMCH
Triangle Compounding Pharmacy
Peking University First Hospital
Affiliated Hospital of Guangdong Public Institution of Medicine
Lorraine's Pharmacy
PLAGH
Institutional Pharmacy Solutions
Ruijin Hospital
Belle Sante
Byculla Pharmacy&Stores
Royal Chemists
Village Compounding Pharmacy
Specialist Pharmacy
Segment by Type
PIA
PAA
CUPM
PDA
SAPM
Segment by Application
Consumers Aged 18 and Younger
Consumers Aged 19 to 44
Consumers Aged 45 to 64
Consumers Aged 65 and Older
By Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
India
Southeast Asia
Australia
Rest of Asia-Pacific
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of Middle East & Africa
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on.
Chapter 2: Revenue of Compounding Pharmacy in global and regional level.
Chapter 3: Detailed analysis of Compounding Pharmacy company competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Compounding Pharmacy revenue, gross margin, and recent development, etc.
Chapter 5: Provides the analysis of various market segments by Type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 6: Provides the analysis of various market segments by Application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 7: North America (US & Canada) by Type, by Application and by country, revenue for each segment.
Chapter 8: Europe by Type, by Application and by country, revenue for each segment.
Chapter 9: Asia Pacific by Type, by Application and by region, revenue for each segment.
Chapter 10: Latin America by Type, by Application and by country, revenue for each segment.
Chapter 11: Middle East and Africa, by Type, by Application and by country, revenue for each segment.
Chapter 12: Analysis of industrial chain, sales channel, key raw materials, distributors, and customers.
Chapter 13: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 14: Research Findings and Conclusion
Table of Contents
1 Study Coverage
1.1 Compounding Pharmacy Product Introduction
1.2 Market by Type
1.2.1 Global Compounding Pharmacy Market Size Growth Rate by Type (2019 VS 2023 VS 2030)
1.2.2 PIA
1.2.3 PAA
1.2.4 CUPM
1.2.5 PDA
1.2.6 SAPM
1.3 Market by Application
1.3.1 Global Compounding Pharmacy Market Size Growth Rate by Application (2019 VS 2023 VS 2030)
1.3.2 Consumers Aged 18 and Younger
1.3.3 Consumers Aged 19 to 44
1.3.4 Consumers Aged 45 to 64
1.3.5 Consumers Aged 65 and Older
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Executive Summary
2.1 Global Compounding Pharmacy Market Size Estimates and Forecasts
2.2 Compounding Pharmacy Market Size by Region: 2023 Versus 2030
2.2.1 Global Compounding Pharmacy Revenue by Region: 2019-2024
2.2.2 Global Compounding Pharmacy Revenue Forecast by Region (2025-2030)
2.2.3 Global Compounding Pharmacy Revenue Market Share by Region (2019-2030)
3 Global Compounding Pharmacy by Company
3.1 Global Compounding Pharmacy Revenue by Company (2019-2024)
3.2 Global Compounding Pharmacy Revenue Share by Company (2019-2024)
3.3 Competitive Landscape
3.3.1 Key Compounding Pharmacy Companies around the World: Ranking by Revenue
3.3.2 Global Compounding Pharmacy Market Concentration Ratio (CR5 and HHI) & (2019-2024)
3.3.3 Global Compounding Pharmacy Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.4 Global Compounding Pharmacy Companies Headquarters & Product Type
3.4.1 Compounding Pharmacy Companies Headquarters
3.4.2 Global Compounding Pharmacy Companies Product & Service
3.4.3 Date of International Companies Enter into Compounding Pharmacy Market
3.5 Global Compounding Pharmacy Mergers & Acquisitions, Expansion Plans
4 Company Profiles
4.1 PharMEDium Services
4.1.1 PharMEDium Services Company Information
4.1.2 PharMEDium Services Description, Business Overview
4.1.3 PharMEDium Services Compounding Pharmacy Products Offered
4.1.4 PharMEDium Services Compounding Pharmacy Revenue and Gross Margin (2019-2024)
4.1.5 PharMEDium Services Compounding Pharmacy Revenue by Product in 2023
4.1.6 PharMEDium Services Compounding Pharmacy Revenue by Application in 2023
4.1.7 PharMEDium Services Compounding Pharmacy Revenue by Geographic Area in 2023
4.1.8 PharMEDium Services Recent Developments
4.2 B. Braun Group
4.2.1 B. Braun Group Company Information
4.2.2 B. Braun Group Description, Business Overview
4.2.3 B. Braun Group Compounding Pharmacy Products Offered
4.2.4 B. Braun Group Compounding Pharmacy Revenue and Gross Margin (2019-2024)
4.2.5 B. Braun Group Compounding Pharmacy Revenue by Product in 2023
4.2.6 B. Braun Group Compounding Pharmacy Revenue by Application in 2023
4.2.7 B. Braun Group Compounding Pharmacy Revenue by Geographic Area in 2023
4.2.8 B. Braun Group Recent Developments
4.3 Fagron
4.3.1 Fagron Company Information
4.3.2 Fagron Description, Business Overview
4.3.3 Fagron Compounding Pharmacy Products Offered
4.3.4 Fagron Compounding Pharmacy Revenue and Gross Margin (2019-2024)
4.3.5 Fagron Compounding Pharmacy Revenue by Product in 2023
4.3.6 Fagron Compounding Pharmacy Revenue by Application in 2023
4.3.7 Fagron Compounding Pharmacy Revenue by Geographic Area in 2023
4.3.8 Fagron Recent Developments
4.4 Wedgewood Pharmacy
4.4.1 Wedgewood Pharmacy Company Information
4.4.2 Wedgewood Pharmacy Description, Business Overview
4.4.3 Wedgewood Pharmacy Compounding Pharmacy Products Offered
4.4.4 Wedgewood Pharmacy Compounding Pharmacy Revenue and Gross Margin (2019-2024)
4.4.5 Wedgewood Pharmacy Compounding Pharmacy Revenue by Product in 2023
4.4.6 Wedgewood Pharmacy Compounding Pharmacy Revenue by Application in 2023
4.4.7 Wedgewood Pharmacy Compounding Pharmacy Revenue by Geographic Area in 2023
4.4.8 Wedgewood Pharmacy Recent Developments
4.5 New Compounding Pharma
4.5.1 New Compounding Pharma Company Information
4.5.2 New Compounding Pharma Description, Business Overview
4.5.3 New Compounding Pharma Compounding Pharmacy Products Offered
4.5.4 New Compounding Pharma Compounding Pharmacy Revenue and Gross Margin (2019-2024)
4.5.5 New Compounding Pharma Compounding Pharmacy Revenue by Product in 2023
4.5.6 New Compounding Pharma Compounding Pharmacy Revenue by Application in 2023
4.5.7 New Compounding Pharma Compounding Pharmacy Revenue by Geographic Area in 2023
4.5.8 New Compounding Pharma Recent Developments
4.6 Medisca
4.6.1 Medisca Company Information
4.6.2 Medisca Description, Business Overview
4.6.3 Medisca Compounding Pharmacy Products Offered
4.6.4 Medisca Compounding Pharmacy Revenue and Gross Margin (2019-2024)
4.6.5 Medisca Compounding Pharmacy Revenue by Product in 2023
4.6.6 Medisca Compounding Pharmacy Revenue by Application in 2023
4.6.7 Medisca Compounding Pharmacy Revenue by Geographic Area in 2023
4.6.8 Medisca Recent Development
4.7 Fresenius Kabi
4.7.1 Fresenius Kabi Company Information
4.7.2 Fresenius Kabi Description, Business Overview
4.7.3 Fresenius Kabi Compounding Pharmacy Products Offered
4.7.4 Fresenius Kabi Compounding Pharmacy Revenue and Gross Margin (2019-2024)
4.7.5 Fresenius Kabi Compounding Pharmacy Revenue by Product in 2023
4.7.6 Fresenius Kabi Compounding Pharmacy Revenue by Application in 2023
4.7.7 Fresenius Kabi Compounding Pharmacy Revenue by Geographic Area in 2023
4.7.8 Fresenius Kabi Recent Development
4.8 Advanced Pharma
4.8.1 Advanced Pharma Company Information
4.8.2 Advanced Pharma Description, Business Overview
4.8.3 Advanced Pharma Compounding Pharmacy Products Offered
4.8.4 Advanced Pharma Compounding Pharmacy Revenue and Gross Margin (2019-2024)
4.8.5 Advanced Pharma Compounding Pharmacy Revenue by Product in 2023
4.8.6 Advanced Pharma Compounding Pharmacy Revenue by Application in 2023
4.8.7 Advanced Pharma Compounding Pharmacy Revenue by Geographic Area in 2023
4.8.8 Advanced Pharma Recent Development
4.9 AIN GROUP
4.9.1 AIN GROUP Company Information
4.9.2 AIN GROUP Description, Business Overview
4.9.3 AIN GROUP Compounding Pharmacy Products Offered
4.9.4 AIN GROUP Compounding Pharmacy Revenue and Gross Margin (2019-2024)
4.9.5 AIN GROUP Compounding Pharmacy Revenue by Product in 2023
4.9.6 AIN GROUP Compounding Pharmacy Revenue by Application in 2023
4.9.7 AIN GROUP Compounding Pharmacy Revenue by Geographic Area in 2023
4.9.8 AIN GROUP Recent Development
4.10 Nihon Chouzai
4.10.1 Nihon Chouzai Company Information
4.10.2 Nihon Chouzai Description, Business Overview
4.10.3 Nihon Chouzai Compounding Pharmacy Products Offered
4.10.4 Nihon Chouzai Compounding Pharmacy Revenue and Gross Margin (2019-2024)
4.10.5 Nihon Chouzai Compounding Pharmacy Revenue by Product in 2023
4.10.6 Nihon Chouzai Compounding Pharmacy Revenue by Application in 2023
4.10.7 Nihon Chouzai Compounding Pharmacy Revenue by Geographic Area in 2023
4.10.8 Nihon Chouzai Recent Development
4.11 Sogo Medical
4.11.1 Sogo Medical Company Information
4.11.2 Sogo Medical Description, Business Overview
4.11.3 Sogo Medical Compounding Pharmacy Products Offered
4.11.4 Sogo Medical Compounding Pharmacy Revenue and Gross Margin (2019-2024)
4.11.5 Sogo Medical Compounding Pharmacy Revenue by Product in 2023
4.11.6 Sogo Medical Compounding Pharmacy Revenue by Application in 2023
4.11.7 Sogo Medical Compounding Pharmacy Revenue by Geographic Area in 2023
4.11.8 Sogo Medical Recent Development
4.12 Dougherty’s Pharmacy
4.12.1 Dougherty’s Pharmacy Company Information
4.12.2 Dougherty’s Pharmacy Description, Business Overview
4.12.3 Dougherty’s Pharmacy Compounding Pharmacy Products Offered
4.12.4 Dougherty’s Pharmacy Compounding Pharmacy Revenue and Gross Margin (2019-2024)
4.12.5 Dougherty’s Pharmacy Compounding Pharmacy Revenue by Product in 2023
4.12.6 Dougherty’s Pharmacy Compounding Pharmacy Revenue by Application in 2023
4.12.7 Dougherty’s Pharmacy Compounding Pharmacy Revenue by Geographic Area in 2023
4.12.8 Dougherty’s Pharmacy Recent Development
4.13 Apollo Pharmacy
4.13.1 Apollo Pharmacy Company Information
4.13.2 Apollo Pharmacy Description, Business Overview
4.13.3 Apollo Pharmacy Compounding Pharmacy Products Offered
4.13.4 Apollo Pharmacy Compounding Pharmacy Revenue and Gross Margin (2019-2024)
4.13.5 Apollo Pharmacy Compounding Pharmacy Revenue by Product in 2023
4.13.6 Apollo Pharmacy Compounding Pharmacy Revenue by Application in 2023
4.13.7 Apollo Pharmacy Compounding Pharmacy Revenue by Geographic Area in 2023
4.13.8 Apollo Pharmacy Recent Development
4.14 Downing Labs
4.14.1 Downing Labs Company Information
4.14.2 Downing Labs Description, Business Overview
4.14.3 Downing Labs Compounding Pharmacy Products Offered
4.14.4 Downing Labs Compounding Pharmacy Revenue and Gross Margin (2019-2024)
4.14.5 Downing Labs Compounding Pharmacy Revenue by Product in 2023
4.14.6 Downing Labs Compounding Pharmacy Revenue by Application in 2023
4.14.7 Downing Labs Compounding Pharmacy Revenue by Geographic Area in 2023
4.14.8 Downing Labs Recent Development
4.15 Qol Holdings
4.15.1 Qol Holdings Company Information
4.15.2 Qol Holdings Description, Business Overview
4.15.3 Qol Holdings Compounding Pharmacy Products Offered
4.15.4 Qol Holdings Compounding Pharmacy Revenue and Gross Margin (2019-2024)
4.15.5 Qol Holdings Compounding Pharmacy Revenue by Product in 2023
4.15.6 Qol Holdings Compounding Pharmacy Revenue by Application in 2023
4.15.7 Qol Holdings Compounding Pharmacy Revenue by Geographic Area in 2023
4.15.8 Qol Holdings Recent Development
4.16 Olympia Pharmacy
4.16.1 Olympia Pharmacy Company Information
4.16.2 Olympia Pharmacy Description, Business Overview
4.16.3 Olympia Pharmacy Compounding Pharmacy Products Offered
4.16.4 Olympia Pharmacy Compounding Pharmacy Revenue and Gross Margin (2019-2024)
4.16.5 Olympia Pharmacy Compounding Pharmacy Revenue by Product in 2023
4.16.6 Olympia Pharmacy Compounding Pharmacy Revenue by Application in 2023
4.16.7 Olympia Pharmacy Compounding Pharmacy Revenue by Geographic Area in 2023
4.16.8 Olympia Pharmacy Recent Development
4.17 PUMCH
4.17.1 PUMCH Company Information
4.17.2 PUMCH Description, Business Overview
4.17.3 PUMCH Compounding Pharmacy Products Offered
4.17.4 PUMCH Compounding Pharmacy Revenue and Gross Margin (2019-2024)
4.17.5 PUMCH Compounding Pharmacy Revenue by Product in 2023
4.17.6 PUMCH Compounding Pharmacy Revenue by Application in 2023
4.17.7 PUMCH Compounding Pharmacy Revenue by Geographic Area in 2023
4.17.8 PUMCH Recent Development
4.18 Triangle Compounding Pharmacy
4.18.1 Triangle Compounding Pharmacy Company Information
4.18.2 Triangle Compounding Pharmacy Description, Business Overview
4.18.3 Triangle Compounding Pharmacy Compounding Pharmacy Products Offered
4.18.4 Triangle Compounding Pharmacy Compounding Pharmacy Revenue and Gross Margin (2019-2024)
4.18.5 Triangle Compounding Pharmacy Compounding Pharmacy Revenue by Product in 2023
4.18.6 Triangle Compounding Pharmacy Compounding Pharmacy Revenue by Application in 2023
4.18.7 Triangle Compounding Pharmacy Compounding Pharmacy Revenue by Geographic Area in 2023
4.18.8 Triangle Compounding Pharmacy Recent Development
4.19 Peking University First Hospital
4.19.1 Peking University First Hospital Company Information
4.19.2 Peking University First Hospital Description, Business Overview
4.19.3 Peking University First Hospital Compounding Pharmacy Products Offered
4.19.4 Peking University First Hospital Compounding Pharmacy Revenue and Gross Margin (2019-2024)
4.19.5 Peking University First Hospital Compounding Pharmacy Revenue by Product in 2023
4.19.6 Peking University First Hospital Compounding Pharmacy Revenue by Application in 2023
4.19.7 Peking University First Hospital Compounding Pharmacy Revenue by Geographic Area in 2023
4.19.8 Peking University First Hospital Recent Development
4.20 Affiliated Hospital of Guangdong Public Institution of Medicine
4.20.1 Affiliated Hospital of Guangdong Public Institution of Medicine Company Information
4.20.2 Affiliated Hospital of Guangdong Public Institution of Medicine Description, Business Overview
4.20.3 Affiliated Hospital of Guangdong Public Institution of Medicine Compounding Pharmacy Products Offered
4.20.4 Affiliated Hospital of Guangdong Public Institution of Medicine Compounding Pharmacy Revenue and Gross Margin (2019-2024)
4.20.5 Affiliated Hospital of Guangdong Public Institution of Medicine Compounding Pharmacy Revenue by Product in 2023
4.20.6 Affiliated Hospital of Guangdong Public Institution of Medicine Compounding Pharmacy Revenue by Application in 2023
4.20.7 Affiliated Hospital of Guangdong Public Institution of Medicine Compounding Pharmacy Revenue by Geographic Area in 2023
4.20.8 Affiliated Hospital of Guangdong Public Institution of Medicine Recent Development
4.21 Lorraine's Pharmacy
4.21.1 Lorraine's Pharmacy Company Information
4.21.2 Lorraine's Pharmacy Description, Business Overview
4.21.3 Lorraine's Pharmacy Compounding Pharmacy Products Offered
4.21.4 Lorraine's Pharmacy Compounding Pharmacy Revenue and Gross Margin (2019-2024)
4.21.5 Lorraine's Pharmacy Compounding Pharmacy Revenue by Product in 2023
4.21.6 Lorraine's Pharmacy Compounding Pharmacy Revenue by Application in 2023
4.21.7 Lorraine's Pharmacy Compounding Pharmacy Revenue by Geographic Area in 2023
4.21.8 Lorraine's Pharmacy Recent Development
4.22 PLAGH
4.22.1 PLAGH Company Information
4.22.2 PLAGH Description, Business Overview
4.22.3 PLAGH Compounding Pharmacy Products Offered
4.22.4 PLAGH Compounding Pharmacy Revenue and Gross Margin (2019-2024)
4.22.5 PLAGH Compounding Pharmacy Revenue by Product in 2023
4.22.6 PLAGH Compounding Pharmacy Revenue by Application in 2023
4.22.7 PLAGH Compounding Pharmacy Revenue by Geographic Area in 2023
4.22.8 PLAGH Recent Development
4.23 Institutional Pharmacy Solutions
4.23.1 Institutional Pharmacy Solutions Company Information
4.23.2 Institutional Pharmacy Solutions Description, Business Overview
4.23.3 Institutional Pharmacy Solutions Compounding Pharmacy Products Offered
4.23.4 Institutional Pharmacy Solutions Compounding Pharmacy Revenue and Gross Margin (2019-2024)
4.23.5 Institutional Pharmacy Solutions Compounding Pharmacy Revenue by Product in 2023
4.23.6 Institutional Pharmacy Solutions Compounding Pharmacy Revenue by Application in 2023
4.23.7 Institutional Pharmacy Solutions Compounding Pharmacy Revenue by Geographic Area in 2023
4.23.8 Institutional Pharmacy Solutions Recent Development
4.24 Ruijin Hospital
4.24.1 Ruijin Hospital Company Information
4.24.2 Ruijin Hospital Description, Business Overview
4.24.3 Ruijin Hospital Compounding Pharmacy Products Offered
4.24.4 Ruijin Hospital Compounding Pharmacy Revenue and Gross Margin (2019-2024)
4.24.5 Ruijin Hospital Compounding Pharmacy Revenue by Product in 2023
4.24.6 Ruijin Hospital Compounding Pharmacy Revenue by Application in 2023
4.24.7 Ruijin Hospital Compounding Pharmacy Revenue by Geographic Area in 2023
4.24.8 Ruijin Hospital Recent Development
4.25 Belle Sante
4.25.1 Belle Sante Company Information
4.25.2 Belle Sante Description, Business Overview
4.25.3 Belle Sante Compounding Pharmacy Products Offered
4.25.4 Belle Sante Compounding Pharmacy Revenue and Gross Margin (2019-2024)
4.25.5 Belle Sante Compounding Pharmacy Revenue by Product in 2023
4.25.6 Belle Sante Compounding Pharmacy Revenue by Application in 2023
4.25.7 Belle Sante Compounding Pharmacy Revenue by Geographic Area in 2023
4.25.8 Belle Sante Recent Development
4.26 Byculla Pharmacy&Stores
4.26.1 Byculla Pharmacy&Stores Company Information
4.26.2 Byculla Pharmacy&Stores Description, Business Overview
4.26.3 Byculla Pharmacy&Stores Compounding Pharmacy Products Offered
4.26.4 Byculla Pharmacy&Stores Compounding Pharmacy Revenue and Gross Margin (2019-2024)
4.26.5 Byculla Pharmacy&Stores Compounding Pharmacy Revenue by Product in 2023
4.26.6 Byculla Pharmacy&Stores Compounding Pharmacy Revenue by Application in 2023
4.26.7 Byculla Pharmacy&Stores Compounding Pharmacy Revenue by Geographic Area in 2023
4.26.8 Byculla Pharmacy&Stores Recent Development
4.27 Royal Chemists
4.27.1 Royal Chemists Company Information
4.27.2 Royal Chemists Description, Business Overview
4.27.3 Royal Chemists Compounding Pharmacy Products Offered
4.27.4 Royal Chemists Compounding Pharmacy Revenue and Gross Margin (2019-2024)
4.27.5 Royal Chemists Compounding Pharmacy Revenue by Product in 2023
4.27.6 Royal Chemists Compounding Pharmacy Revenue by Application in 2023
4.27.7 Royal Chemists Compounding Pharmacy Revenue by Geographic Area in 2023
4.27.8 Royal Chemists Recent Development
4.28 Village Compounding Pharmacy
4.28.1 Village Compounding Pharmacy Company Information
4.28.2 Village Compounding Pharmacy Description, Business Overview
4.28.3 Village Compounding Pharmacy Compounding Pharmacy Products Offered
4.28.4 Village Compounding Pharmacy Compounding Pharmacy Revenue and Gross Margin (2019-2024)
4.28.5 Village Compounding Pharmacy Compounding Pharmacy Revenue by Product in 2023
4.28.6 Village Compounding Pharmacy Compounding Pharmacy Revenue by Application in 2023
4.28.7 Village Compounding Pharmacy Compounding Pharmacy Revenue by Geographic Area in 2023
4.28.8 Village Compounding Pharmacy Recent Development
4.29 Specialist Pharmacy
4.29.1 Specialist Pharmacy Company Information
4.29.2 Specialist Pharmacy Description, Business Overview
4.29.3 Specialist Pharmacy Compounding Pharmacy Products Offered
4.29.4 Specialist Pharmacy Compounding Pharmacy Revenue and Gross Margin (2019-2024)
4.29.5 Specialist Pharmacy Compounding Pharmacy Revenue by Product in 2023
4.29.6 Specialist Pharmacy Compounding Pharmacy Revenue by Application in 2023
4.29.7 Specialist Pharmacy Compounding Pharmacy Revenue by Geographic Area in 2023
4.29.8 Specialist Pharmacy Recent Development
5 Breakdown Data by Type
5.1 Global Compounding Pharmacy Revenue by Type (2019-2024)
5.2 Global Compounding Pharmacy Revenue Forecast by Type (2025-2030)
5.3 Compounding Pharmacy Revenue Market Share by Type (2019-2030)
6 Breakdown Data by Application
6.1 Global Compounding Pharmacy Revenue by Application (2019-2024)
6.2 Global Compounding Pharmacy Revenue Forecast by Application (2025-2030)
6.3 Compounding Pharmacy Revenue Market Share by Application (2019-2030)
7 North America
7.1 North America Compounding Pharmacy Market Size YoY Growth 2019-2030
7.2 North America Compounding Pharmacy Market Facts & Figures by Country (2019-2030)
7.3 North America Compounding Pharmacy Revenue by Type (2019-2024)
7.4 North America Compounding Pharmacy Revenue by Application (2019-2024)
8 Asia-Pacific
8.1 Asia-Pacific Compounding Pharmacy Market Size YoY Growth 2019-2030
8.2 Asia-Pacific Compounding Pharmacy Market Facts & Figures by Region (2019-2030)
8.3 Asia-Pacific Compounding Pharmacy Revenue by Type (2019-2024)
8.4 Asia-Pacific Compounding Pharmacy Revenue by Application (2019-2024)
9 Europe
9.1 Europe Compounding Pharmacy Market Size YoY Growth 2019-2030
9.2 Europe Compounding Pharmacy Market Facts & Figures by Country (2019-2030)
9.3 Europe Compounding Pharmacy Revenue by Type (2019-2024)
9.4 Europe Compounding Pharmacy Revenue by Application (2019-2024)
10 Latin America
10.1 Latin America Compounding Pharmacy Market Size YoY Growth 2019-2030
10.2 Latin America Compounding Pharmacy Market Facts & Figures by Country (2019-2030)
10.3 Latin America Compounding Pharmacy Revenue by Type (2019-2024)
10.4 Latin America Compounding Pharmacy Revenue by Application (2019-2024)
11 Middle East and Africa
11.1 Middle East and Africa Compounding Pharmacy Market Size YoY Growth 2019-2030
11.2 Middle East and Africa Compounding Pharmacy Market Facts & Figures by Country (2019-2030)
11.3 Middle East and Africa Compounding Pharmacy Revenue by Type (2019-2024)
11.4 Middle East and Africa Compounding Pharmacy Revenue by Application (2019-2024)
12 Supply Chain and Sales Channel Analysis
12.1 Compounding Pharmacy Supply Chain Analysis
12.2 Compounding Pharmacy Key Raw Materials and Upstream Suppliers
12.3 Compounding Pharmacy Clients Analysis
12.4 Compounding Pharmacy Sales Channel and Sales Model Analysis
12.4.1 Compounding Pharmacy Distribution Channel Analysis: Indirect Sales VS Direct Sales
12.4.2 Compounding Pharmacy Distribution Channel Analysis: Online Sales VS Offline Sales
12.4.3 Compounding Pharmacy Distributors
13 Market Dynamics
13.1 Compounding Pharmacy Industry Trends
13.2 Compounding Pharmacy Market Drivers
13.3 Compounding Pharmacy Market Challenges
13.4 Compounding Pharmacy Market Restraints
14 Research Findings and Conclusion
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer
List of Tables Table 1. Global Compounding Pharmacy Market Size Growth Rate by Type (US$ Million): 2019 VS 2023 VS 2030 Table 2. Major Companies of PIA Table 3. Major Companies of PAA Table 4. Major Companies of CUPM Table 5. Major Companies of PDA Table 6. Major Companies of SAPM Table 7. Global Compounding Pharmacy Market Size Growth by Application (US$ Million): 2019 VS 2023 VS 2030 Table 8. Global Compounding Pharmacy Market Size by Region (US$ Million): 2023 VS 2030 Table 9. Global Compounding Pharmacy Revenue by Region (2019-2024) & (US$ Million) Table 10. Global Compounding Pharmacy Revenue Forecast by Region (2025-2030) & (US$ Million) Table 11. Compounding Pharmacy Revenue by Company (2019-2024) & (US$ Million) Table 12. Compounding Pharmacy Revenue Share by Company (2019-2024) Table 13. Ranking of Global Top Compounding Pharmacy Players by Revenue (US$ Million) in 2023 Table 14. Global Compounding Pharmacy Companies Market Concentration Ratio (CR5 and HHI) & (2019-2024) Table 15. Global Compounding Pharmacy by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Compounding Pharmacy as of 2023) Table 16. Global Compounding Pharmacy Companies Headquarters Table 17. Global Compounding Pharmacy Companies Product & Service Table 18. Date of International Companies Enter into Compounding Pharmacy Market Table 19. Global Compounding Pharmacy Mergers & Acquisitions, Expansion Plans Table 20. PharMEDium Services Company Information Table 21. PharMEDium Services Description and Business Overview Table 22. PharMEDium Services Compounding Pharmacy Product Table 23. PharMEDium Services Compounding Pharmacy Revenue (US$ Million) and Gross Margin (2019-2024) Table 24. PharMEDium Services Revenue Proportion of Compounding Pharmacy by Product in 2023 Table 25. PharMEDium Services Revenue Proportion of Compounding Pharmacy by Application in 2023 Table 26. PharMEDium Services Revenue Proportion of Compounding Pharmacy by Geographic Area in 2023 Table 27. PharMEDium Services Recent Development Table 28. B. Braun Group Company Information Table 29. B. Braun Group Description and Business Overview Table 30. B. Braun Group Compounding Pharmacy Product Table 31. B. Braun Group Compounding Pharmacy Revenue (US$ Million) and Gross Margin (2019-2024) Table 32. B. Braun Group Revenue Proportion of Compounding Pharmacy by Product in 2023 Table 33. B. Braun Group Revenue Proportion of Compounding Pharmacy by Application in 2023 Table 34. B. Braun Group Revenue Proportion of Compounding Pharmacy by Geographic Area in 2023 Table 35. B. Braun Group Recent Development Table 36. Fagron Company Information Table 37. Fagron Description and Business Overview Table 38. Fagron Compounding Pharmacy Product Table 39. Fagron Compounding Pharmacy Revenue (US$ Million) and Gross Margin (2019-2024) Table 40. Fagron Revenue Proportion of Compounding Pharmacy by Product in 2023 Table 41. Fagron Revenue Proportion of Compounding Pharmacy by Application in 2023 Table 42. Fagron Revenue Proportion of Compounding Pharmacy by Geographic Area in 2023 Table 43. Fagron Recent Development Table 44. Wedgewood Pharmacy Company Information Table 45. Wedgewood Pharmacy Description and Business Overview Table 46. Wedgewood Pharmacy Compounding Pharmacy Product Table 47. Wedgewood Pharmacy Compounding Pharmacy Revenue (US$ Million) and Gross Margin (2019-2024) Table 48. Wedgewood Pharmacy Revenue Proportion of Compounding Pharmacy by Product in 2023 Table 49. Wedgewood Pharmacy Revenue Proportion of Compounding Pharmacy by Application in 2023 Table 50. Wedgewood Pharmacy Revenue Proportion of Compounding Pharmacy by Geographic Area in 2023 Table 51. Wedgewood Pharmacy Recent Development Table 52. New Compounding Pharma Company Information Table 53. New Compounding Pharma Description and Business Overview Table 54. New Compounding Pharma Compounding Pharmacy Product Table 55. New Compounding Pharma Compounding Pharmacy Revenue (US$ Million) and Gross Margin (2019-2024) Table 56. New Compounding Pharma Revenue Proportion of Compounding Pharmacy by Product in 2023 Table 57. New Compounding Pharma Revenue Proportion of Compounding Pharmacy by Application in 2023 Table 58. New Compounding Pharma Revenue Proportion of Compounding Pharmacy by Geographic Area in 2023 Table 59. New Compounding Pharma Recent Development Table 60. Medisca Company Information Table 61. Medisca Description and Business Overview Table 62. Medisca Compounding Pharmacy Product Table 63. Medisca Compounding Pharmacy Revenue (US$ Million) and Gross Margin (2019-2024) Table 64. Medisca Revenue Proportion of Compounding Pharmacy by Product in 2023 Table 65. Medisca Revenue Proportion of Compounding Pharmacy by Application in 2023 Table 66. Medisca Revenue Proportion of Compounding Pharmacy by Geographic Area in 2023 Table 67. Medisca Recent Development Table 68. Fresenius Kabi Company Information Table 69. Fresenius Kabi Description and Business Overview Table 70. Fresenius Kabi Compounding Pharmacy Product Table 71. Fresenius Kabi Compounding Pharmacy Revenue (US$ Million) and Gross Margin (2019-2024) Table 72. Fresenius Kabi Revenue Proportion of Compounding Pharmacy by Product in 2023 Table 73. Fresenius Kabi Revenue Proportion of Compounding Pharmacy by Application in 2023 Table 74. Fresenius Kabi Revenue Proportion of Compounding Pharmacy by Geographic Area in 2023 Table 75. Fresenius Kabi Recent Development Table 76. Advanced Pharma Company Information Table 77. Advanced Pharma Description and Business Overview Table 78. Advanced Pharma Compounding Pharmacy Product Table 79. Advanced Pharma Compounding Pharmacy Revenue (US$ Million) and Gross Margin (2019-2024) Table 80. Advanced Pharma Revenue Proportion of Compounding Pharmacy by Product in 2023 Table 81. Advanced Pharma Revenue Proportion of Compounding Pharmacy by Application in 2023 Table 82. Advanced Pharma Revenue Proportion of Compounding Pharmacy by Geographic Area in 2023 Table 83. Advanced Pharma Recent Development Table 84. AIN GROUP Company Information Table 85. AIN GROUP Description and Business Overview Table 86. AIN GROUP Compounding Pharmacy Product Table 87. AIN GROUP Compounding Pharmacy Revenue (US$ Million) and Gross Margin (2019-2024) Table 88. AIN GROUP Revenue Proportion of Compounding Pharmacy by Product in 2023 Table 89. AIN GROUP Revenue Proportion of Compounding Pharmacy by Application in 2023 Table 90. AIN GROUP Revenue Proportion of Compounding Pharmacy by Geographic Area in 2023 Table 91. AIN GROUP Recent Development Table 92. Nihon Chouzai Company Information Table 93. Nihon Chouzai Description and Business Overview Table 94. Nihon Chouzai Compounding Pharmacy Product Table 95. Nihon Chouzai Compounding Pharmacy Revenue (US$ Million) and Gross Margin (2019-2024) Table 96. Nihon Chouzai Revenue Proportion of Compounding Pharmacy by Product in 2023 Table 97. Nihon Chouzai Revenue Proportion of Compounding Pharmacy by Application in 2023 Table 98. Nihon Chouzai Revenue Proportion of Compounding Pharmacy by Geographic Area in 2023 Table 99. Nihon Chouzai Recent Development Table 100. Sogo Medical Company Information Table 101. Sogo Medical Description and Business Overview Table 102. Sogo Medical Compounding Pharmacy Product Table 103. Sogo Medical Compounding Pharmacy Revenue (US$ Million) and Gross Margin (2019-2024) Table 104. Sogo Medical Revenue Proportion of Compounding Pharmacy by Product in 2023 Table 105. Sogo Medical Revenue Proportion of Compounding Pharmacy by Application in 2023 Table 106. Sogo Medical Revenue Proportion of Compounding Pharmacy by Geographic Area in 2023 Table 107. Sogo Medical Recent Development Table 108. Dougherty’s Pharmacy Company Information Table 109. Dougherty’s Pharmacy Description and Business Overview Table 110. Dougherty’s Pharmacy Compounding Pharmacy Product Table 111. Dougherty’s Pharmacy Compounding Pharmacy Revenue (US$ Million) and Gross Margin (2019-2024) Table 112. Dougherty’s Pharmacy Revenue Proportion of Compounding Pharmacy by Product in 2023 Table 113. Dougherty’s Pharmacy Revenue Proportion of Compounding Pharmacy by Application in 2023 Table 114. Dougherty’s Pharmacy Revenue Proportion of Compounding Pharmacy by Geographic Area in 2023 Table 115. Dougherty’s Pharmacy Recent Development Table 116. Apollo Pharmacy Company Information Table 117. Apollo Pharmacy Description and Business Overview Table 118. Apollo Pharmacy Compounding Pharmacy Product Table 119. Apollo Pharmacy Compounding Pharmacy Revenue (US$ Million) and Gross Margin (2019-2024) Table 120. Apollo Pharmacy Revenue Proportion of Compounding Pharmacy by Product in 2023 Table 121. Apollo Pharmacy Revenue Proportion of Compounding Pharmacy by Application in 2023 Table 122. Apollo Pharmacy Revenue Proportion of Compounding Pharmacy by Geographic Area in 2023 Table 123. Apollo Pharmacy Recent Development Table 124. Downing Labs Company Information Table 125. Downing Labs Description and Business Overview Table 126. Downing Labs Compounding Pharmacy Product Table 127. Downing Labs Compounding Pharmacy Revenue (US$ Million) and Gross Margin (2019-2024) Table 128. Downing Labs Revenue Proportion of Compounding Pharmacy by Product in 2023 Table 129. Downing Labs Revenue Proportion of Compounding Pharmacy by Application in 2023 Table 130. Downing Labs Revenue Proportion of Compounding Pharmacy by Geographic Area in 2023 Table 131. Downing Labs Recent Development Table 132. Qol Holdings Company Information Table 133. Qol Holdings Description and Business Overview Table 134. Qol Holdings Compounding Pharmacy Product Table 135. Qol Holdings Compounding Pharmacy Revenue (US$ Million) and Gross Margin (2019-2024) Table 136. Qol Holdings Revenue Proportion of Compounding Pharmacy by Product in 2023 Table 137. Qol Holdings Revenue Proportion of Compounding Pharmacy by Application in 2023 Table 138. Qol Holdings Revenue Proportion of Compounding Pharmacy by Geographic Area in 2023 Table 139. Qol Holdings Recent Development Table 140. Olympia Pharmacy Company Information Table 141. Olympia Pharmacy Description and Business Overview Table 142. Olympia Pharmacy Compounding Pharmacy Product Table 143. Olympia Pharmacy Compounding Pharmacy Revenue (US$ Million) and Gross Margin (2019-2024) Table 144. Olympia Pharmacy Revenue Proportion of Compounding Pharmacy by Product in 2023 Table 145. Olympia Pharmacy Revenue Proportion of Compounding Pharmacy by Application in 2023 Table 146. Olympia Pharmacy Revenue Proportion of Compounding Pharmacy by Geographic Area in 2023 Table 147. Olympia Pharmacy Recent Development Table 148. PUMCH Company Information Table 149. PUMCH Description and Business Overview Table 150. PUMCH Compounding Pharmacy Product Table 151. PUMCH Compounding Pharmacy Revenue (US$ Million) and Gross Margin (2019-2024) Table 152. PUMCH Revenue Proportion of Compounding Pharmacy by Product in 2023 Table 153. PUMCH Revenue Proportion of Compounding Pharmacy by Application in 2023 Table 154. PUMCH Revenue Proportion of Compounding Pharmacy by Geographic Area in 2023 Table 155. PUMCH Recent Development Table 156. Triangle Compounding Pharmacy Company Information Table 157. Triangle Compounding Pharmacy Description and Business Overview Table 158. Triangle Compounding Pharmacy Compounding Pharmacy Product Table 159. Triangle Compounding Pharmacy Compounding Pharmacy Revenue (US$ Million) and Gross Margin (2019-2024) Table 160. Triangle Compounding Pharmacy Revenue Proportion of Compounding Pharmacy by Product in 2023 Table 161. Triangle Compounding Pharmacy Revenue Proportion of Compounding Pharmacy by Application in 2023 Table 162. Triangle Compounding Pharmacy Revenue Proportion of Compounding Pharmacy by Geographic Area in 2023 Table 163. Triangle Compounding Pharmacy Recent Development Table 164. Peking University First Hospital Company Information Table 165. Peking University First Hospital Description and Business Overview Table 166. Peking University First Hospital Compounding Pharmacy Product Table 167. Peking University First Hospital Compounding Pharmacy Revenue (US$ Million) and Gross Margin (2019-2024) Table 168. Peking University First Hospital Revenue Proportion of Compounding Pharmacy by Product in 2023 Table 169. Peking University First Hospital Revenue Proportion of Compounding Pharmacy by Application in 2023 Table 170. Peking University First Hospital Revenue Proportion of Compounding Pharmacy by Geographic Area in 2023 Table 171. Peking University First Hospital Recent Development Table 172. Affiliated Hospital of Guangdong Public Institution of Medicine Company Information Table 173. Affiliated Hospital of Guangdong Public Institution of Medicine Description and Business Overview Table 174. Affiliated Hospital of Guangdong Public Institution of Medicine Compounding Pharmacy Product Table 175. Affiliated Hospital of Guangdong Public Institution of Medicine Compounding Pharmacy Revenue (US$ Million) and Gross Margin (2019-2024) Table 176. Affiliated Hospital of Guangdong Public Institution of Medicine Revenue Proportion of Compounding Pharmacy by Product in 2023 Table 177. Affiliated Hospital of Guangdong Public Institution of Medicine Revenue Proportion of Compounding Pharmacy by Application in 2023 Table 178. Affiliated Hospital of Guangdong Public Institution of Medicine Revenue Proportion of Compounding Pharmacy by Geographic Area in 2023 Table 179. Affiliated Hospital of Guangdong Public Institution of Medicine Recent Development Table 180. Lorraine's Pharmacy Company Information Table 181. Lorraine's Pharmacy Description and Business Overview Table 182. Lorraine's Pharmacy Compounding Pharmacy Product Table 183. Lorraine's Pharmacy Compounding Pharmacy Revenue (US$ Million) and Gross Margin (2019-2024) Table 184. Lorraine's Pharmacy Revenue Proportion of Compounding Pharmacy by Product in 2023 Table 185. Lorraine's Pharmacy Revenue Proportion of Compounding Pharmacy by Application in 2023 Table 186. Lorraine's Pharmacy Revenue Proportion of Compounding Pharmacy by Geographic Area in 2023 Table 187. Lorraine's Pharmacy Recent Development Table 188. PLAGH Company Information Table 189. PLAGH Description and Business Overview Table 190. PLAGH Compounding Pharmacy Product Table 191. PLAGH Compounding Pharmacy Revenue (US$ Million) and Gross Margin (2019-2024) Table 192. PLAGH Revenue Proportion of Compounding Pharmacy by Product in 2023 Table 193. PLAGH Revenue Proportion of Compounding Pharmacy by Application in 2023 Table 194. PLAGH Revenue Proportion of Compounding Pharmacy by Geographic Area in 2023 Table 195. PLAGH Recent Development Table 196. Institutional Pharmacy Solutions Company Information Table 197. Institutional Pharmacy Solutions Description and Business Overview Table 198. Institutional Pharmacy Solutions Compounding Pharmacy Product Table 199. Institutional Pharmacy Solutions Compounding Pharmacy Revenue (US$ Million) and Gross Margin (2019-2024) Table 200. Institutional Pharmacy Solutions Revenue Proportion of Compounding Pharmacy by Product in 2023 Table 201. Institutional Pharmacy Solutions Revenue Proportion of Compounding Pharmacy by Application in 2023 Table 202. Institutional Pharmacy Solutions Revenue Proportion of Compounding Pharmacy by Geographic Area in 2023 Table 203. Institutional Pharmacy Solutions Recent Development Table 204. Ruijin Hospital Company Information Table 205. Ruijin Hospital Description and Business Overview Table 206. Ruijin Hospital Compounding Pharmacy Product Table 207. Ruijin Hospital Compounding Pharmacy Revenue (US$ Million) and Gross Margin (2019-2024) Table 208. Ruijin Hospital Revenue Proportion of Compounding Pharmacy by Product in 2023 Table 209. Ruijin Hospital Revenue Proportion of Compounding Pharmacy by Application in 2023 Table 210. Ruijin Hospital Revenue Proportion of Compounding Pharmacy by Geographic Area in 2023 Table 211. Ruijin Hospital Recent Development Table 212. Belle Sante Company Information Table 213. Belle Sante Description and Business Overview Table 214. Belle Sante Compounding Pharmacy Product Table 215. Belle Sante Compounding Pharmacy Revenue (US$ Million) and Gross Margin (2019-2024) Table 216. Belle Sante Revenue Proportion of Compounding Pharmacy by Product in 2023 Table 217. Belle Sante Revenue Proportion of Compounding Pharmacy by Application in 2023 Table 218. Belle Sante Revenue Proportion of Compounding Pharmacy by Geographic Area in 2023 Table 219. Belle Sante Recent Development Table 220. Byculla Pharmacy&Stores Company Information Table 221. Byculla Pharmacy&Stores Description and Business Overview Table 222. Byculla Pharmacy&Stores Compounding Pharmacy Product Table 223. Byculla Pharmacy&Stores Compounding Pharmacy Revenue (US$ Million) and Gross Margin (2019-2024) Table 224. Byculla Pharmacy&Stores Revenue Proportion of Compounding Pharmacy by Product in 2023 Table 225. Byculla Pharmacy&Stores Revenue Proportion of Compounding Pharmacy by Application in 2023 Table 226. Byculla Pharmacy&Stores Revenue Proportion of Compounding Pharmacy by Geographic Area in 2023 Table 227. Byculla Pharmacy&Stores Recent Development Table 228. Royal Chemists Company Information Table 229. Royal Chemists Description and Business Overview Table 230. Royal Chemists Compounding Pharmacy Product Table 231. Royal Chemists Compounding Pharmacy Revenue (US$ Million) and Gross Margin (2019-2024) Table 232. Royal Chemists Revenue Proportion of Compounding Pharmacy by Product in 2023 Table 233. Royal Chemists Revenue Proportion of Compounding Pharmacy by Application in 2023 Table 234. Royal Chemists Revenue Proportion of Compounding Pharmacy by Geographic Area in 2023 Table 235. Royal Chemists Recent Development Table 236. Village Compounding Pharmacy Company Information Table 237. Village Compounding Pharmacy Description and Business Overview Table 238. Village Compounding Pharmacy Compounding Pharmacy Product Table 239. Village Compounding Pharmacy Compounding Pharmacy Revenue (US$ Million) and Gross Margin (2019-2024) Table 240. Village Compounding Pharmacy Revenue Proportion of Compounding Pharmacy by Product in 2023 Table 241. Village Compounding Pharmacy Revenue Proportion of Compounding Pharmacy by Application in 2023 Table 242. Village Compounding Pharmacy Revenue Proportion of Compounding Pharmacy by Geographic Area in 2023 Table 243. Village Compounding Pharmacy Recent Development Table 244. Specialist Pharmacy Company Information Table 245. Specialist Pharmacy Description and Business Overview Table 246. Specialist Pharmacy Compounding Pharmacy Product Table 247. Specialist Pharmacy Compounding Pharmacy Revenue (US$ Million) and Gross Margin (2019-2024) Table 248. Specialist Pharmacy Revenue Proportion of Compounding Pharmacy by Product in 2023 Table 249. Specialist Pharmacy Revenue Proportion of Compounding Pharmacy by Application in 2023 Table 250. Specialist Pharmacy Revenue Proportion of Compounding Pharmacy by Geographic Area in 2023 Table 251. Specialist Pharmacy Recent Development Table 252. Global Compounding Pharmacy Revenue by Type (2019-2024) & (US$ Million) Table 253. Global Compounding Pharmacy Revenue Forecast by Type (2025-2030) & (US$ Million) Table 254. Global Compounding Pharmacy Revenue by Application (2019-2024) & (US$ Million) Table 255. Global Compounding Pharmacy Revenue Forecast by Application (2025-2030) & (US$ Million) Table 256. North America Compounding Pharmacy Revenue by Country (2019-2024) & (US$ Million) Table 257. North America Compounding Pharmacy Revenue by Country (2025-2030) & (US$ Million) Table 258. North America Compounding Pharmacy Revenue by Type (2019-2024) & (US$ Million) Table 259. North America Compounding Pharmacy Revenue by Application (2019-2024) & (US$ Million) Table 260. Asia-Pacific Compounding Pharmacy Revenue by Region (2019-2030) & (US$ Million) Table 261. Asia-Pacific Compounding Pharmacy Revenue by Region (2025-2030) & (US$ Million) Table 262. Asia-Pacific Compounding Pharmacy Revenue by Type (2019-2024) & (US$ Million) Table 263. Asia-Pacific Compounding Pharmacy Revenue by Application (2019-2024) & (US$ Million) Table 264. Europe Compounding Pharmacy Revenue by Country (2019-2024) & (US$ Million) Table 265. Europe Compounding Pharmacy Revenue by Country (2025-2030) & (US$ Million) Table 266. Europe Compounding Pharmacy Revenue by Type (2019-2024) & (US$ Million) Table 267. Europe Compounding Pharmacy Revenue by Application (2019-2024) & (US$ Million) Table 268. Latin America Compounding Pharmacy Revenue by Country (2019-2024) & (US$ Million) Table 269. Latin America Compounding Pharmacy Revenue by Country (2025-2030) & (US$ Million) Table 270. Latin America Compounding Pharmacy Revenue by Type (2019-2024) & (US$ Million) Table 271. Latin America Compounding Pharmacy Revenue by Application (2019-2024) & (US$ Million) Table 272. Middle East and Africa Compounding Pharmacy Revenue by Country (2019-2024) & (US$ Million) Table 273. Middle East and Africa Compounding Pharmacy Revenue by Country (2025-2030) & (US$ Million) Table 274. Middle East and Africa Compounding Pharmacy Revenue by Type (2019-2024) & (US$ Million) Table 275. Middle East and Africa Compounding Pharmacy Revenue by Application (2019-2024) & (US$ Million) Table 276. Compounding Pharmacy Key Raw Materials, Industry Status and Trend Table 277. Compounding Pharmacy Key Raw Materials and Upstream Suppliers Table 278. Compounding Pharmacy Clients Status and Trend Table 279. Compounding Pharmacy Typical Clients Table 280. Compounding Pharmacy Distributors Table 281. Compounding Pharmacy Market Trends Table 282. Compounding Pharmacy Market Drivers Table 283. Compounding Pharmacy Market Challenges Table 284. Compounding Pharmacy Market Restraints Table 285. Research Programs/Design for This Report Table 286. Key Data Information from Secondary Sources Table 287. Key Data Information from Primary Sources List of Figures Figure 1. Compounding Pharmacy Product Picture Figure 2. Global Compounding Pharmacy Revenue Market Share by Type in 2023 & 2030 Figure 3. PIA Product Picture Figure 4. PAA Product Picture Figure 5. CUPM Product Picture Figure 6. PDA Product Picture Figure 7. SAPM Product Picture Figure 8. Global Compounding Pharmacy Revenue Market Share by Application in 2023 & 2030 Figure 9. Consumers Aged 18 and Younger Figure 10. Consumers Aged 19 to 44 Figure 11. Consumers Aged 45 to 64 Figure 12. Consumers Aged 65 and Older Figure 13. Compounding Pharmacy Report Years Considered Figure 14. Global Compounding Pharmacy Revenue, (US$ Million), 2019 VS 2023 VS 2030 Figure 15. Global Compounding Pharmacy Market Size 2019-2030 (US$ Million) Figure 16. Global Compounding Pharmacy Market Size Market Share by Region: 2023 Versus 2030 Figure 17. Global Compounding Pharmacy Revenue Market Share by Region (2019-2030) Figure 18. Compounding Pharmacy Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2019 VS 2023 Figure 19. Global Compounding Pharmacy Revenue Market Share Forecast by Type (2019-2030) Figure 20. Global Compounding Pharmacy Revenue Market Share Forecast by Application (2019-2030) Figure 21. North America Compounding Pharmacy Revenue 2019-2030 (US$ Million) Figure 22. North America Compounding Pharmacy Revenue Market Share by Type (2019-2024) Figure 23. North America Compounding Pharmacy Revenue Market Share by Application (2019-2024) Figure 24. Asia-Pacific Compounding Pharmacy Revenue 2019-2030 (US$ Million) Figure 25. Asia-Pacific Compounding Pharmacy Revenue Market Share by Region (2019-2030) Figure 26. Asia-Pacific Compounding Pharmacy Revenue Market Share by Type (2019-2024) Figure 27. Asia-Pacific Compounding Pharmacy Revenue Market Share by Application (2019-2024) Figure 28. Europe Compounding Pharmacy Revenue Growth Rate 2019-2030 (US$ Million) Figure 29. Europe Compounding Pharmacy Revenue Market Share by Country (2019-2030) Figure 30. Europe Compounding Pharmacy Revenue Market Share by Type (2019-2024) Figure 31. Europe Compounding Pharmacy Revenue Market Share by Application (2019-2024) Figure 32. Latin America Compounding Pharmacy Revenue Growth Rate 2019-2030 (US$ Million) Figure 33. Latin America Compounding Pharmacy Revenue Market Share by Country (2019-2024) Figure 34. Latin America Compounding Pharmacy Revenue Market Share by Type (2019-2024) Figure 35. Latin America Compounding Pharmacy Revenue Market Share by Application (2019-2024) Figure 36. Middle East and Africa Compounding Pharmacy Revenue Growth Rate 2019-2030 (US$ Million) Figure 37. Middle East and Africa Compounding Pharmacy Revenue Market Share by Country (2019-2030) Figure 38. Middle East and Africa Compounding Pharmacy Revenue Market Share by Type (2019-2024) Figure 39. Middle East and Africa Compounding Pharmacy Revenue Market Share by Application (2019-2024) Figure 40. Compounding Pharmacy Supply Chain (Upstream and Downstream Market) Figure 41. Global Production Market Share of Compounding Pharmacy Raw Materials by Region in 2023 Figure 42. Compounding Pharmacy Distribution Channels Figure 43. Global Compounding Pharmacy Percentage 2019-2030: Indirect Sales VS Direct Sales Figure 44. Global Compounding Pharmacy Percentage 2019-2030: Online Sales VS Offline Sales Figure 45. Bottom-up and Top-down Approaches for This Report Figure 46. Data Triangulation Figure 47. Key Executives Interviewed Figure 48. Global Compounding Pharmacy Percentage 2019-2030: Online Sales VS Offline Sales Figure 49. Bottom-up and Top-down Approaches for This Report Figure 50. Data Triangulation Figure 51. Key Executives Interviewed
